Cancer Research Technology
Log in Register
Menu

Anti-BCLAF1 [M33-P5B11]

Invented by Ayham Alnabulsi at Vertebrate Antibodies Limited

Info

Catalogue Number 151874
Applications ELISA IHC WB
Antigen/Gene or Protein Targets BCL2 Associated Transcription Factor 1 (BCLAF1)
Reactivity Human
Relevance BCLAF1 was associated with poor prognosis and showed aberrant localization in colorectal cancer.
Host Mouse
Immunogen Peptide Sequence - KYQGDGIVED (amino acids 900 – 909)
Subclass IgG1 kappa
Positive Control ELISA- Peptide immunogenWestern Blot- Hela whole cell extractIHC- Human colon carcinoma
Recommended Growing Conditions Dulbecco’s media containing 20% Fetal Bovine serum (DH20) prepared as follows (for final volume of 300ml: 237ml DMEM + 60 ml Fetal Bovine Serum plus 3ml L-Glutamine(Sigma G7513) + 3ml of Penicillin -Streptomycin (Sigma P0781).
Strain Balb/c
Research Area Apoptosis and Programmed Cell Death, Cancer, Epigenetics & Nuclear Signalling

References: 2 entries

Brown et al. 2016. Histopathology. 68(4):556-66. PMID: 26183150.

IHC WB

The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy.

Europe PMC ID: 26183150


Add a reference

References: 2 entries

Brown et al. 2016. Histopathology. 68(4):556-66. PMID: 26183150.

IHC WB

The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy.

Europe PMC ID: 26183150


Add a reference

References: 2 entries

Brown et al. 2016. Histopathology. 68(4):556-66. PMID: 26183150.

IHC WB

The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy.


Add a reference


This reagent does not have any reviews at the moment.